Definium Therapeutics, Inc. is trading 4.3% down today at $22.02 as the stock extends a multi-day pullback amid broader macro and interest rate concerns.
- The move follows last week’s sharp price swings and aligns with recent declines in growth names and high-beta therapeutics stocks.
- There is no fresh company-specific news today, indicating the downward pressure is likely driven by softer market-wide risk appetite.